glp-1 employer coverage news october 2025 Who Gets the Shot? Access by State Medicare GLP-1 Drug Coverage -

A retrospective study showed that HbA1c improved significantly during the first year of treatment and this effect was maintained over four years, although the benefits plateaued after the first year

Additionally, a personal or family history of specific health issues, such as medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2, is a major red flag

This ongoing innovation promises a future where these powerful hormonal therapies can be tailored more precisely to individual patient needs, offering new hope for a variety of chronic diseases

It is uncertain whether these findings are detrimental or beneficial for the patient